Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Dr. Huda Y. Zoghbi awarded for genetics and neurodegenerative diseases research.

2018 Ross Prize in Molecular Medicine — Genetics of Neurodevelopmental Disorders

Tuesday, June 5, 2018, 12:30 PM - 5:30 PM EDT

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

 

The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries transformed the way medicine is practiced. The awardees are midcareer researchers who have made a significant impact in the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine.

The 2018 Ross Prize in Molecular Medicine will be awarded to Dr. Huda Y. Zoghbi for her research unveiling the genetic and molecular basis of Rett syndrome and spinocerebellar ataxia, enabling novel therapeutic strategies for these devastating diseases. Her discovery of the mutational driver of Rett syndrome also lead to the elucidation of its role in other neurological impairments, ranging from learning disabilities to autism. Complemented by fundamental studies in neurodevelopment, Dr. Zoghbi continues to pursue the complex molecular processes driving the pathogenesis of some of the most devastating neurological conditions.

Registration

Individual
$5

Keynote Speaker

Huda Y. Zoghbi, MD, Baylor College of Medicine
Huda Y. Zoghbi, MD, Baylor College of Medicine

Speakers

Mary E. Hatten, PhD, The Rockefeller University
Mary E. Hatten, PhD, The Rockefeller University
Nathaniel Heintz, PhD, The Rockefeller University
Nathaniel Heintz, PhD, The Rockefeller University

Tuesday

June 05, 2018

12:30 PM

Registration and Refreshments

1:00 PM

Welcome and Introductory Remarks

Speakers

Kevin J. Tracey, MD
The Feinstein Institute for Medical Research
Jack and Robin Ross
The Feinstein Institute for Medical Research Board of Directors
Kari Fischer, PhD
The New York Academy of Sciences

Session I: 2018 Ross Prize in Molecular Medicine Presentation and Lecture

1:30 PM

2018 Ross Prize in Molecular Medicine Announcement and Presentation

Speaker

Betty Diamond, MD
The Feinstein Institute for Medical Research
1:40 PM

2018 Ross Prize in Molecular Medicine Acceptance

Speaker

Huda Y. Zoghbi, MD
Baylor College of Medicine; Howard Hughes Medical Institute; Texas Children’s Hospital
1:45 PM

Genetic and Neurophysiological Approaches to Tackle Neurodevelopmental Disorders

Speaker

Huda Y. Zoghbi, MD
Baylor College of Medicine; Howard Hughes Medical Institute; Texas Children’s Hospital
2:45 PM

Networking Break

Session II: Healthy and Pathologic Neurodevelopment

3:15 PM

Mechanisms of Cerebellar Development: Migration, Circuit Formation and Synaptic Plasticity

Speaker

Mary E. Hatten, PhD
The Rockefeller University
3:45 PM

Cells, Circuits and CNS Complexity: Circuit Specific Strategies for CNS Therapy

Speaker

Nathaniel Heintz, PhD
The Rockefeller University; Howard Hughes Medical Institute
4:15 PM

Closing Remarks

Speaker

Betty Diamond, MD
The Feinstein Institute for Medical Research
4:30 PM

Wine and Cheese Reception

5:30 PM

Adjourn